2-Bromo-4-methoxy-1,3-thiazole

Catalog No. :
ACLJFP819
CAS No. :
1121583-56-9
Molecular Formula :
C4H4BrNOS
Molecular Weight :
194.05

IUPAC Name:2-bromo-4-methoxythiazole

2-Bromo-4-methoxy-1,3-thiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$168.00Login to see priceIn stockInquiry
50mg95%$235.00Login to see priceIn stockInquiry
100mg95%$329.00Login to see priceIn stockInquiry
250mg95%$460.00Login to see priceIn stockInquiry
1g95%$1003.00Login to see priceIn stockInquiry
5g95%$4714.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-4-methoxy-1,3-thiazole
IUPAC Name2-bromo-4-methoxythiazole
MDL No.MFCD22479565
Molecular FormulaC4H4BrNOS
Molecular Weight194.05
SMILESCOC1=CSC(Br)=N1
InChI KeyOYZSBVWESQQMCK-UHFFFAOYSA-N
Synonym2-bromo-4-methoxy-1,3-thiazole;Thiazole, 2-bromo-4-methoxy-
CAS No.1121583-56-9
PubChem CID58107318

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLJFP819 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACLJFP819 route product structure diagram
    ACLJFP8191121583-56-9 In Stock
Inquiry

2. ACLJFP819 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACNJFG124 route compound structure diagram
    ACNJFG124139670-03-4 In Stock
  4. Then
  5. ACLJFP819 route product structure diagram
    ACLJFP8191121583-56-9 In Stock
Inquiry

Comments (0)